Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart. Published Online First: 23 September 2009. doi:10.1136/hrt.2009.177162
Copyright © 2009 BMJ Publishing Group Ltd & British Cardiovascular Society

Original articles

Multivessel Coronary Disease in ST-Elevation Myocardial Infarction: Three Different Revascularization Strategies and Long-Term Outcomes

Luigi Politi 1*, Fabio Sgura 1, Rosario Rossi 1, Daniel Monopoli 1, Elisa Guerri 1, Chiara Leuzzi 1, Francesca Bursi 1, Giuseppe Massimo Sangiorgi 1 and Maria Grazia Modena 1

1 Institute of Cardiology, Policlinico University Hospital, Modena, Italy

* To whom correspondence should be addressed. E-mail: luigi.politi{at}unimore.it.

Accepted 25 August 2009


Abstract

Background: Few reports described outcomes of complete compared with infarct related artery (IRA) only revascularization in patients with ST elevation myocardial infarction (STEMI) and multivessel coronary disease (CAD). Moreover there are no studies comparing simultaneous treatment of non-IRAs with the IRA treatment followed by elective procedure for the other lesions (staged revascularization).

Methods: We studied the outcomes of 214 consecutive patients with STEMI and multivessel CAD undergoing primary angioplasty. Before the first angioplasty patients were randomized to 3 different strategies: 1) culprit vessel angioplasty only (COR group), 2) staged revascularization (SR group), and 3) simultaneous treatment of non-IRAs (CR group).

Results: During a mean follow-up of 2.5 years, 42 (50.0%) patients in COR group experienced at least one major adverse cardiac event (MACE), 13 (20.0%) in SR group, and 15 (23.1%) in CR group, p<0.001. In-hospital death, repeat revascularization and re-hospitalization occurred more frequently in COR group (all p<0.05), while there was no significant difference in re-infarction among the 3 groups. Survival free of MACE was significantly reduced in COR group but it was similar in CR and SR groups.

Conclusions: Culprit vessel only angioplasty was associated with the highest rate of long-term MACE as compared to multivessel treatment. Patients scheduled for staged revascularization experienced a similar rate of MACE as patients undergoing complete simultaneous treatment of non-IRAs.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.